000 01709 a2200517 4500
005 20250517120714.0
264 0 _c20170728
008 201707s 0 0 eng d
022 _a1559-0100
024 7 _a10.1007/s12020-016-1120-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVroonen, Laurent
245 0 0 _aProspective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia.
_h[electronic resource]
260 _bEndocrine
_c01 2017
300 _a239-245 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aCabergoline
650 0 4 _aDopamine Agonists
_xpharmacology
650 0 4 _aEchocardiography
650 0 4 _aErgolines
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHeart Valve Diseases
_xdiagnostic imaging
650 0 4 _aHeart Valves
_xdiagnostic imaging
650 0 4 _aHumans
650 0 4 _aHyperprolactinemia
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPituitary Neoplasms
_xdrug therapy
650 0 4 _aProlactinoma
_xcomplications
650 0 4 _aProspective Studies
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aLancellotti, Patrizio
700 1 _aGarcia, Monica Tomé
700 1 _aDulgheru, Raluca
700 1 _aRubio-Almanza, Matilde
700 1 _aMaiga, Ibrahima
700 1 _aMagne, Julien
700 1 _aPetrossians, Patrick
700 1 _aAuriemma, Renata
700 1 _aDaly, Adrian F
700 1 _aBeckers, Albert
773 0 _tEndocrine
_gvol. 55
_gno. 1
_gp. 239-245
856 4 0 _uhttps://doi.org/10.1007/s12020-016-1120-5
_zAvailable from publisher's website
999 _c26489372
_d26489372